ZANGRILLI, ARIANNA
ZANGRILLI, ARIANNA
Dipartimento di Medicina dei sistemi
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report
2020-11-11 Piccolo, A; Pensa, C; Zangrilli, A; Bavetta, M; Diluvio, L; Bianchi, L
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic
2021-10-20 Hansel, K; Zangrilli, A; Bianchi, L; Peris, K; Chiricozzi, A; Offidani, A; Diotallevi, F; Fargnoli, Mc; Esposito, M; Amerio, P; Gualdi, G; Bianchi, L; Stingeni, L
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study
2008-01-01 Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics
2007-01-01 Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation
2020-04-06 Zangrilli, A; Bavetta, M; Bianchi, L
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation
2019-10-03 Lernia, Vd; Bianchi, L; Guerriero, C; Stingeni, L; Gisondi, P; Filoni, A; Guarneri, C; Belloni Fortina, A; Lasagni, C; Simonetti, O; Neri, I; Zangrilli, A; Moretta, G; Hansel, K; Casanova, Dm; Girolomoni, G; Cannavò, Sp; Bonamonte, D
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
2013-01-01 Saraceno, R; Bavetta, M; Zangrilli, A; Chiricozzi, A; Potenza, C; Chimenti, S; Chimenti, Ms
Clinical severity instruments
2005-01-01 Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
2014-11-01 Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience
2023-01-01 Caldarola, G; Zangrilli, A; Palmisano, G; Bavetta, M; Moretta, G; Pagnanelli, G; Panasiti, V; Bianchi, L; De Simone, C; Peris, K
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
2019-01-01 Esposito, M; Prignano, F; Rongioletti, F; Hansel, K; Bianchi, L; Pescitelli, L; Lazzeri, L; Ricceri, F; Mugheddu, C; Bavetta, M; Zangrilli, A; Bianchi, L; Bini, V; Stingeni, L
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis
2020-01-01 Lanna, C; Zangrilli, A; Bavetta, M; Campione, E; Bianchi, L
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study
2013-01-01 Esposito, M; Giunta, A; Mazzotta, A; Zangrilli, A; Babino, G; Bavetta, M; Perricone, R; Chimenti, S; Chimenti, Ms
Erysipeloid cutaneous metastasis from bladder carcinoma
2007-01-01 Zangrilli, A; Saraceno, R; Sarmati, L; Orlandi, A; Bianchi, L; Chimenti, S
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.
2017-01-01 Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L
Ixekizumab: One drug for an enigmatic psoriasis
2020-06-18 Piccolo, A; Pensa, C; Zangrilli, A; Bavetta, M; Orlandi, A; Bianchi, L
Long-term efficacy of adalimumab in generalized pustular psoriasis
2008-01-01 Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index.
2018-01-01 Zangrilli, A; Bavetta, M; Scaramella, M; Bianchi, L
Omalizumab and adalimumab: a winning couple
2020-01-01 Diluvio, L; Vollono, L; Zangrilli, A; Manfreda, V; Prete, Md; Massaro, A; Modica, S; Greco, E; Bianchi, L; Campione, E
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast
2019-01-01 Lanna, C; Mazzilli, S; Zangrilli, A; Bianchi, L; Campione, E
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 11-nov-2020 | A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report | Piccolo, A; Pensa, C; Zangrilli, A; Bavetta, M; Diluvio, L; Bianchi, L | Articolo su rivista | |
| 20-ott-2021 | A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic | Hansel, K; Zangrilli, A; Bianchi, L; Peris, K; Chiricozzi, A; Offidani, A; Diotallevi, F; Fargnoli, Mc; Esposito, M; Amerio, P; Gualdi, G; Bianchi, L; Stingeni, L | Articolo su rivista | |
| 1-gen-2008 | Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study | Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S | Intervento a convegno | |
| 1-gen-2007 | Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics | Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
| 6-apr-2020 | Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation | Zangrilli, A; Bavetta, M; Bianchi, L | Articolo su rivista | |
| 3-ott-2019 | Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation | Lernia, Vd; Bianchi, L; Guerriero, C; Stingeni, L; Gisondi, P; Filoni, A; Guarneri, C; Belloni Fortina, A; Lasagni, C; Simonetti, O; Neri, I; Zangrilli, A; Moretta, G; Hansel, K; Casanova, Dm; Girolomoni, G; Cannavò, Sp; Bonamonte, D | Articolo su rivista | |
| 1-gen-2013 | Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis | Saraceno, R; Bavetta, M; Zangrilli, A; Chiricozzi, A; Potenza, C; Chimenti, S; Chimenti, Ms | Articolo su rivista | |
| 1-gen-2005 | Clinical severity instruments | Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S | Contributo in libro | |
| 1-nov-2014 | Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations | Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
| 1-gen-2023 | Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience | Caldarola, G; Zangrilli, A; Palmisano, G; Bavetta, M; Moretta, G; Pagnanelli, G; Panasiti, V; Bianchi, L; De Simone, C; Peris, K | Articolo su rivista | |
| 1-gen-2019 | Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice | Esposito, M; Prignano, F; Rongioletti, F; Hansel, K; Bianchi, L; Pescitelli, L; Lazzeri, L; Ricceri, F; Mugheddu, C; Bavetta, M; Zangrilli, A; Bianchi, L; Bini, V; Stingeni, L | Articolo su rivista | |
| 1-gen-2020 | Efficacy and safety of Adalimumab in difficult-to-treat psoriasis | Lanna, C; Zangrilli, A; Bavetta, M; Campione, E; Bianchi, L | Articolo su rivista | |
| 1-gen-2013 | Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study | Esposito, M; Giunta, A; Mazzotta, A; Zangrilli, A; Babino, G; Bavetta, M; Perricone, R; Chimenti, S; Chimenti, Ms | Articolo su rivista | |
| 1-gen-2007 | Erysipeloid cutaneous metastasis from bladder carcinoma | Zangrilli, A; Saraceno, R; Sarmati, L; Orlandi, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
| 1-gen-2017 | HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. | Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L | Articolo su rivista | |
| 18-giu-2020 | Ixekizumab: One drug for an enigmatic psoriasis | Piccolo, A; Pensa, C; Zangrilli, A; Bavetta, M; Orlandi, A; Bianchi, L | Articolo su rivista | |
| 1-gen-2008 | Long-term efficacy of adalimumab in generalized pustular psoriasis | Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S | Articolo su rivista | |
| 1-gen-2018 | Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. | Zangrilli, A; Bavetta, M; Scaramella, M; Bianchi, L | Articolo su rivista | |
| 1-gen-2020 | Omalizumab and adalimumab: a winning couple | Diluvio, L; Vollono, L; Zangrilli, A; Manfreda, V; Prete, Md; Massaro, A; Modica, S; Greco, E; Bianchi, L; Campione, E | Articolo su rivista | |
| 1-gen-2019 | One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast | Lanna, C; Mazzilli, S; Zangrilli, A; Bianchi, L; Campione, E | Articolo su rivista |